The new science-driven bodycare brand strengthens Foxtale's evolution into a category-defining House of Brands and channels existing clinical formulation expertise…
If approved, lecanemab would be the first and only anti-amyloid treatment in Japan to offer an at-home injection from the…
Delivers exceptional clarity with lower additive levels, streamlining production and expanding formulation options for converters and resin producers SPARTANBURG, S.C.,…
Through Week 56 in the SOLARIS trial, there were no suspected or confirmed post-injection delirium/sedation syndrome (PDSS) events observed with…
Real-world claims studies evaluating UZEDY® (risperidone) also show improved adherence and persistence rates, fewer inpatient, outpatient and emergency department (ED)…